Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

p53 tumor suppressor protein regulates the levels of huntingtin gene expression

Abstract

The p53 protein is a transcription factor that integrates various cellular stress signals. The accumulation of the mutant huntingtin protein with an expanded polyglutamine tract plays a central role in the pathology of human Huntington's disease. We found that the huntingtin gene contains multiple putative p53-responsive elements and p53 binds to these elements both in vivo and in vitro. p53 activation in cultured human cells, either by a temperature-sensitive mutant p53 protein or by gamma-irradiation (γ-irradiation), increases huntingtin mRNA and protein expression. Similarly, murine huntingtin also contains multiple putative p53-responsive elements and its expression is induced by p53 activation in cultured cells. Moreover, γ-irradiation, which activates p53, increases huntingtin gene expression in the striatum and cortex of mouse brain, the major pathological sites for Huntington's disease, in p53+/+ but not the isogenic p53−/− mice. These results demonstrate that p53 protein can regulate huntingtin expression at transcriptional level, and suggest that a p53 stress response could be a modulator of the process of Huntington's disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Anca MH, Gazit E, Loewenthal R, Ostrovsky O, Frydman M, Giladi N . (2004). Am J Med Genet A 124: 89–91.

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Science 282: 1497–1501.

  • DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP et al. (1997). Science 277: 1990–1993.

  • Dixon KT, Cearley JA, Hunter JM, Detloff PJ . (2004). Gene Expr 11: 221–231.

  • el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B . (1992). Nat Genet 1: 45–49.

  • Georgiou N, Bradshaw JL, Chiu E, Tudor A, O'Gorman L, Phillips JG . (1999). Mov Disord 14: 320–325.

  • Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J . (2002). Proc Natl Acad Sci USA 99: 8467–8472.

  • Huntington's Disease Collaborative Research Group (1993). Cell 72: 971–983.

  • Jin S, Levine AJ . (2001). J Cell Sci 114: 4139–4140.

  • Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H . (2002). J Biol Chem 277: 30838–30843.

  • Levine AJ . (1997). Cell 88: 323–331.

  • Li SH, Li XJ . (2004). Trends Genet 20: 146–154.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T . (1993). Nature 362: 847–849.

  • Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J et al. (1995). Cell 81: 811–823.

  • Pochampally R, Fodera B, Chen L, Lu W, Chen J . (1999). J Biol Chem 274: 15271–15277.

  • Sharp AH, Ross CA . (1996). Neurobiol Dis 3: 3–15.

  • Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H et al. (2000). Proc Natl Acad Sci USA 97: 6763–6768.

  • Trushina E, Dyer RB, Badger II JD, Ure D, Eide L, Tran DD et al. (2004). Mol Cell Biol 24: 8195–8209.

  • Vogelstein B, Lane D, Levine AJ . (2000). Nature 408: 307–310.

  • Wu X, Levine AJ . (1994). Proc Natl Acad Sci USA 91: 3602–3606.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A J Levine.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, Z., Jin, S., Zupnick, A. et al. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25, 1–7 (2006). https://doi.org/10.1038/sj.onc.1209021

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209021

Keywords

This article is cited by

Search

Quick links